{"ticker": {"uuid": "713a9946-d527-4b88-9a4e-75e6e04c5542", "symbol": "HKPD", "name": "Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Medical Distribution"}, "articles": [{"title": "Hong Kong Pharma Digital Technology Holdings Ltd", "summary": "This article provides a technical analysis of Hong Kong Pharma Digital Technology Holdings Ltd (HKPD), including its support, resistance levels, indicators, and moving averages. The analysis presents a summarized view of buy, sell, and neutral signals based on various technical i", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-hkpd/technical", "source_name": "TradingKey", "published_at": "2026-06-25T13:40:20", "published_display": "25 Jun 2026 13:40", "sentiment": "negative", "sentiment_pct": 28, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hong Kong Pharma Digital Technology Holdings Ltd (HKPD) Earnings Forecast: Future EPS & Revenue Growth Estimates \u2014 TradingKey", "summary": "The TradingKey platform provides an overview of Hong Kong Pharma Digital Technology Holdings Ltd (HKPD), including its current stock price, market cap, and a general analysis framework. However, the section for earnings forecast, EPS, revenue, net profit, and EBIT indicates that ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-hkpd/earnings", "source_name": "TradingKey", "published_at": "2026-06-18T03:39:26", "published_display": "18 Jun 2026 03:39", "sentiment": "negative", "sentiment_pct": 40, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hong Kong Pharma Digital Technology Holdings Ltd (HKPD) Valuation: PE, PB & Fair Value Analysis", "summary": "This article provides a valuation analysis for Hong Kong Pharma Digital Technology Holdings Ltd (HKPD), focusing on its P/E, P/B, and Fair Value. As of the report, relevant P/E, P/B, P/S, and P/CF data have not been disclosed by the company. The stock is currently trading at 0.40", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-hkpd/company-valuation", "source_name": "TradingKey", "published_at": "2026-06-18T01:39:41", "published_display": "18 Jun 2026 01:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hong Kong Pharma Digital Technology Holdings Ltd (HKPD) Financial Health: Profitability & Balance Sheet Analysis", "summary": "This article from TradingKey analyzes the financial health of Hong Kong Pharma Digital Technology Holdings Ltd (HKPD), focusing on profitability and balance sheet aspects. It notes that relevant financial data regarding cash, assets, liabilities, free cash flow, revenue, operatin", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-hkpd/financial-health", "source_name": "TradingKey", "published_at": "2026-06-18T01:39:26", "published_display": "18 Jun 2026 01:39", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hong Kong Pharma Digital Technology Holdings Ltd (HKPD) Institutional Confidence", "summary": "This article from TradingKey focuses on the institutional confidence in Hong Kong Pharma Digital Technology Holdings Ltd (HKPD). It presents a list of institutional shareholders, their shareholdings, and changes in their positions. The company's stock performance shows a recent d", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-hkpd/sentiment", "source_name": "TradingKey", "published_at": "2026-06-18T01:39:26", "published_display": "18 Jun 2026 01:39", "sentiment": "negative", "sentiment_pct": 33, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[Form 3] Cellyan Biotechnology Co., Ltd Initial Statement of Beneficial Ownership", "summary": "Cellyan Biotechnology Co., Ltd director Wong Lap Sun has filed an initial Form 3, reporting beneficial ownership of 18,468 Class A Ordinary Shares. This filing establishes his direct holdings in the company and serves as a baseline for future insider transactions, without indicat", "url": "https://www.stocktitan.net/sec-filings/HKPD/form-3-cellyan-biotechnology-co-ltd-initial-statement-of-beneficial-o-6715c86b6bb6.html", "source_name": "Stock Titan", "published_at": "2026-06-10T19:39:00", "published_display": "10 Jun 2026 19:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Articles from Hong Kong Pharma Digital Technology Holdings Ltd", "summary": "Hong Kong Pharma Digital Technology Holdings Limited announced that all proposals were duly passed at its 2025 annual meeting of stockholders held on December 12, 2025. The company, a leading provider of over-the-counter pharmaceutical cross-border e-commerce supply chain service", "url": "https://www.financialcontent.com/article/publisher/Hong%20Kong%20Pharma%20Digital%20Technology%20Holdings%20Ltd", "source_name": "FinancialContent", "published_at": "2026-04-27T12:40:36", "published_display": "27 Apr 2026 12:40", "sentiment": "positive", "sentiment_pct": 71, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "12.5M shares for resale \u2014 Cellyan Biotechnology (NASDAQ: HKPD)", "summary": "Cellyan Biotechnology (NASDAQ: HKPD) has filed an F-1 registration statement for the resale of up to 12.5 million Class A Ordinary Shares by existing shareholders from a March 2026 private placement. The company will not receive any proceeds from these sales, which will be conduc", "url": "https://www.stocktitan.net/sec-filings/HKPD/f-1-cellyan-biotechnology-co-ltd-foreign-issuer-ipo-registration-db213894c20b.html", "source_name": "Stock Titan", "published_at": "2026-03-27T19:39:32", "published_display": "27 Mar 2026 19:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cellyan Biotechnology (HKPD) completes $6.5M private unit financing", "summary": "Cellyan Biotechnology (HKPD) has successfully completed a private placement, raising approximately $6.5 million by selling 12,499,986 units at $0.52 each. Each unit includes a Class A ordinary share and two three-year warrants with a low exercise price of $0.01 per share. The pro", "url": "https://www.stocktitan.net/sec-filings/HKPD/6-k-cellyan-biotechnology-co-ltd-current-report-foreign-issuer-c2d7f705ffc2.html", "source_name": "Stock Titan", "published_at": "2026-03-27T09:39:32", "published_display": "27 Mar 2026 09:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HKPD Stock News Today | Earnings, Events & Price Alerts", "summary": "This page provides a consolidated view of news and events related to HKPD stock, including recent corporate announcements and past financial news. Key updates include Nasdaq non-compliance warnings for Cellyan Biotechnology (HKPD), capital restructuring approvals, and previous IP", "url": "https://intellectia.ai/en/stock/HKPD/news", "source_name": "Intellectia AI", "published_at": "2026-03-02T21:51:57", "published_display": "02 Mar 2026 21:51", "sentiment": "negative", "sentiment_pct": 40, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cellyan Biotechnology Hit With Nasdaq Bid-Price Deficiency Notice, Shares Remain Listed", "summary": "Cellyan Biotechnology Co., Ltd (formerly Hong Kong Pharma Digital Technology Holdings Ltd.) received a Nasdaq bid-price deficiency notice because its Class A ordinary shares traded below US$1.00 for 30 consecutive business days. The company has 180 calendar days to regain complia", "url": "https://www.theglobeandmail.com/investing/markets/stocks/HKPD-Q/pressreleases/37099649/cellyan-biotechnology-hit-with-nasdaq-bid-price-deficiency-notice-shares-remain-listed/", "source_name": "The Globe and Mail", "published_at": "2026-01-18T12:57:47", "published_display": "18 Jan 2026 12:57", "sentiment": "negative", "sentiment_pct": 20, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cellyan Biotechnology Co., Ltd Receives Nasdaq Notice of Bid Price Deficiency", "summary": "Cellyan Biotechnology Co., Ltd (Nasdaq: HKPD) has received a notice from Nasdaq regarding non-compliance with the minimum bid price requirement. The company's share price was below $1.00 for 30 consecutive business days. Cellyan Biotechnology Co., Ltd has 180 calendar days to reg", "url": "https://www.manilatimes.net/2026/01/17/tmt-newswire/globenewswire/cellyan-biotechnology-co-ltd-receives-nasdaq-notice-of-bid-price-deficiency/2260560", "source_name": "The Manila Times", "published_at": "2026-01-17T21:58:21", "published_display": "17 Jan 2026 21:58", "sentiment": "negative", "sentiment_pct": 29, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cellyan Biotechnology (NASDAQ: HKPD) warned on bid price rule compliance", "summary": "Cellyan Biotechnology (NASDAQ: HKPD) has received a notice from Nasdaq regarding its non-compliance with the minimum bid price requirement. The company's Class A ordinary shares traded below US$1.00 for 30 consecutive business days, triggering the warning. Cellyan Biotechnology h", "url": "https://www.stocktitan.net/sec-filings/HKPD/6-k-cellyan-biotechnology-co-ltd-current-report-foreign-issuer-700aee91ec16.html", "source_name": "Stock Titan", "published_at": "2026-01-16T20:10:12", "published_display": "16 Jan 2026 20:10", "sentiment": "negative", "sentiment_pct": 28, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cellyan Biotechnology (Nasdaq:HKPD) - Stock Analysis", "summary": "This Simply Wall St analysis provides a comprehensive overview of Cellyan Biotechnology (Nasdaq:HKPD), an investment holding company involved in OTC pharmaceutical business in Hong Kong and Mainland China. The report covers its financials, including a market cap of US$7.3m, curre", "url": "https://simplywall.st/stocks/us/transportation/nasdaq-hkpd/cellyan-biotechnology", "source_name": "Simply Wall St", "published_at": "2026-01-03T20:53:11", "published_display": "03 Jan 2026 20:53", "sentiment": "negative", "sentiment_pct": 30, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hong Kong Pharma Digital Technology Announces Board Changes", "summary": "The article \"Hong Kong Pharma Digital Technology Announces Board Changes\" contains no substantive content beyond its title. No further information about the board changes, the company, or relevant dates is provided in the input.", "url": "https://www.msn.com/en-us/money/savingandinvesting/hong-kong-pharma-digital-technology-announces-board-changes/ar-AA1QknFQ?apiversion=v2&domshim=1&noservercache=1&noservertelemetry=1&batchservertelemetry=1&renderwebcomponents=1&wcseo=1", "source_name": "MSN", "published_at": "2025-12-31T00:09:33", "published_display": "31 Dec 2025 00:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hong Kong Pharma Digital Announced Results of 2025 Annual Meeting of Stockholders", "summary": "Hong Kong Pharma Digital Technology Holdings Limited (NASDAQ: HKPD) announced that all proposals presented at its 2025 annual meeting of stockholders on December 12, 2025, were duly passed. Key approvals include the re-election of five directors, ratification of an independent ac", "url": "https://news.futunn.com/en/post/66334011/hong-kong-pharma-digital-announced-results-of-2025-annual-meeting", "source_name": "\u5bcc\u9014\u725b\u725b", "published_at": "2025-12-22T03:22:53", "published_display": "22 Dec 2025 03:22", "sentiment": "positive", "sentiment_pct": 60, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insiders Who Purchased US$6.90m Of Hong Kong Pharma Digital Technology Holdings Stock May Not Have Expected 19% Tumble", "summary": "", "url": "https://news.google.com/rss/articles/CBMi_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?oc=5", "source_name": "simplywall.st", "published_at": "2025-12-03T08:00:00+00:00", "published_display": "03 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hong Kong Pharma Stocks Surge as AIM Vaccine Secures U.S. Clinical Approval for mRNA RSV Vaccine", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1gFBVV95cUxQT3pjVWdQU2FXMm5fRnJXamZSb05xNDdGSXFnazRuWkRyLWMxaTdNaC1ySExJYS1TNHJtTElXWFpfbEh0cjl0dXpLVE5PdjZTY2pQVV9jOEJhcjlmd1J1SVlMbmVpNmNnSlNCZ2p1bWZZTmpnRXRwOVFKTnhtOXlzZ0VJODdlWEdGN3gydFhTX0paOWFNcXBRakR3aVdrajNWM1FLWnZFYzZ2VUpqSXJmaWtSUVBVZjZhSEttUWtDb3Fha1VZTlZfRzJ6TDVqQk5YM2lNaUtR?oc=5", "source_name": "BioPharma APAC", "published_at": "2025-02-27T08:00:00+00:00", "published_display": "27 Feb 2025 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hong Kong Pharma Digital Tech Holdings Ltd Rings the Opening Bell", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxQNlVidlQ1eTRzRUxTQW1lNXVOSXBucnNLVGZSV2xpSWd0LXlhbUtSSFpRT1BMZnloOENfUkphY2UtUzNIMFRlanlKcUhjcDBjTFF1WEpheU51U2JmME9HZ3lfeXJVWmdqMHM5TGtYR0EyWkM5Ynp1VnlxdGx2Ylh2Y3JsYXNZV1JENzZ3QnlPNEVKcHRLZmc?oc=5", "source_name": "Nasdaq", "published_at": "2025-01-23T08:00:00+00:00", "published_display": "23 Jan 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMiX0FVX3lxTE5nVUU1TklYbWRpLWR5SFNwMTFjYjM4S196LWJXd0RVZEd3N3dHeDNDcGRyd3MzVTdIa0dpYTUwbUtvRnlJd3RUejV1ZUxnZXNydVg0NVRxb0hmRFV2bWpV?oc=5", "source_name": "CoinCodex", "published_at": "2025-01-16T08:24:41+00:00", "published_display": "16 Jan 2025 08:24", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HKPD Stock Price and Chart \u2014 NASDAQ:HKPD", "summary": "", "url": "https://news.google.com/rss/articles/CBMiXEFVX3lxTFBEYzl4Y00tT1Vhbk51aExvVll2dXdLT2dpMzR5U01YQk1YX0NGT2NRdkUzem8zOUJNd0VLd3o3WlY0RlhGNlpORUt4dDcteXBNLUR0YkNrMWdUV1Aw?oc=5", "source_name": "TradingView", "published_at": "2025-01-15T18:55:31+00:00", "published_display": "15 Jan 2025 18:55", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Hong Kong Pharma Digital Technology Holdings Ltd", "summary": "This article provides a technical analysis of Hong Kong Pharma Digital Technology Holdings Ltd (HKPD), including its support, resistance levels, indicators, and moving averages. The analysis presents a summarized view of buy, sell, and neutral signals based on various technical i", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-hkpd/technical", "source_name": "TradingKey", "published_at": "2026-06-25T13:40:20", "published_display": "25 Jun 2026 13:40", "sentiment": "negative", "sentiment_pct": 28, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hong Kong Pharma Digital Technology Holdings Ltd (HKPD) Earnings Forecast: Future EPS & Revenue Growth Estimates \u2014 TradingKey", "summary": "The TradingKey platform provides an overview of Hong Kong Pharma Digital Technology Holdings Ltd (HKPD), including its current stock price, market cap, and a general analysis framework. However, the section for earnings forecast, EPS, revenue, net profit, and EBIT indicates that ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-hkpd/earnings", "source_name": "TradingKey", "published_at": "2026-06-18T03:39:26", "published_display": "18 Jun 2026 03:39", "sentiment": "negative", "sentiment_pct": 40, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hong Kong Pharma Digital Technology Holdings Ltd (HKPD) Valuation: PE, PB & Fair Value Analysis", "summary": "This article provides a valuation analysis for Hong Kong Pharma Digital Technology Holdings Ltd (HKPD), focusing on its P/E, P/B, and Fair Value. As of the report, relevant P/E, P/B, P/S, and P/CF data have not been disclosed by the company. The stock is currently trading at 0.40", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-hkpd/company-valuation", "source_name": "TradingKey", "published_at": "2026-06-18T01:39:41", "published_display": "18 Jun 2026 01:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hong Kong Pharma Digital Technology Holdings Ltd (HKPD) Financial Health: Profitability & Balance Sheet Analysis", "summary": "This article from TradingKey analyzes the financial health of Hong Kong Pharma Digital Technology Holdings Ltd (HKPD), focusing on profitability and balance sheet aspects. It notes that relevant financial data regarding cash, assets, liabilities, free cash flow, revenue, operatin", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-hkpd/financial-health", "source_name": "TradingKey", "published_at": "2026-06-18T01:39:26", "published_display": "18 Jun 2026 01:39", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hong Kong Pharma Digital Technology Holdings Ltd (HKPD) Institutional Confidence", "summary": "This article from TradingKey focuses on the institutional confidence in Hong Kong Pharma Digital Technology Holdings Ltd (HKPD). It presents a list of institutional shareholders, their shareholdings, and changes in their positions. The company's stock performance shows a recent d", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-hkpd/sentiment", "source_name": "TradingKey", "published_at": "2026-06-18T01:39:26", "published_display": "18 Jun 2026 01:39", "sentiment": "negative", "sentiment_pct": 33, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[Form 3] Cellyan Biotechnology Co., Ltd Initial Statement of Beneficial Ownership", "summary": "Cellyan Biotechnology Co., Ltd director Wong Lap Sun has filed an initial Form 3, reporting beneficial ownership of 18,468 Class A Ordinary Shares. This filing establishes his direct holdings in the company and serves as a baseline for future insider transactions, without indicat", "url": "https://www.stocktitan.net/sec-filings/HKPD/form-3-cellyan-biotechnology-co-ltd-initial-statement-of-beneficial-o-6715c86b6bb6.html", "source_name": "Stock Titan", "published_at": "2026-06-10T19:39:00", "published_display": "10 Jun 2026 19:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Articles from Hong Kong Pharma Digital Technology Holdings Ltd", "summary": "Hong Kong Pharma Digital Technology Holdings Limited announced that all proposals were duly passed at its 2025 annual meeting of stockholders held on December 12, 2025. The company, a leading provider of over-the-counter pharmaceutical cross-border e-commerce supply chain service", "url": "https://www.financialcontent.com/article/publisher/Hong%20Kong%20Pharma%20Digital%20Technology%20Holdings%20Ltd", "source_name": "FinancialContent", "published_at": "2026-04-27T12:40:36", "published_display": "27 Apr 2026 12:40", "sentiment": "positive", "sentiment_pct": 71, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "12.5M shares for resale \u2014 Cellyan Biotechnology (NASDAQ: HKPD)", "summary": "Cellyan Biotechnology (NASDAQ: HKPD) has filed an F-1 registration statement for the resale of up to 12.5 million Class A Ordinary Shares by existing shareholders from a March 2026 private placement. The company will not receive any proceeds from these sales, which will be conduc", "url": "https://www.stocktitan.net/sec-filings/HKPD/f-1-cellyan-biotechnology-co-ltd-foreign-issuer-ipo-registration-db213894c20b.html", "source_name": "Stock Titan", "published_at": "2026-03-27T19:39:32", "published_display": "27 Mar 2026 19:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cellyan Biotechnology (HKPD) completes $6.5M private unit financing", "summary": "Cellyan Biotechnology (HKPD) has successfully completed a private placement, raising approximately $6.5 million by selling 12,499,986 units at $0.52 each. Each unit includes a Class A ordinary share and two three-year warrants with a low exercise price of $0.01 per share. The pro", "url": "https://www.stocktitan.net/sec-filings/HKPD/6-k-cellyan-biotechnology-co-ltd-current-report-foreign-issuer-c2d7f705ffc2.html", "source_name": "Stock Titan", "published_at": "2026-03-27T09:39:32", "published_display": "27 Mar 2026 09:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HKPD Stock News Today | Earnings, Events & Price Alerts", "summary": "This page provides a consolidated view of news and events related to HKPD stock, including recent corporate announcements and past financial news. Key updates include Nasdaq non-compliance warnings for Cellyan Biotechnology (HKPD), capital restructuring approvals, and previous IP", "url": "https://intellectia.ai/en/stock/HKPD/news", "source_name": "Intellectia AI", "published_at": "2026-03-02T21:51:57", "published_display": "02 Mar 2026 21:51", "sentiment": "negative", "sentiment_pct": 40, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cellyan Biotechnology Hit With Nasdaq Bid-Price Deficiency Notice, Shares Remain Listed", "summary": "Cellyan Biotechnology Co., Ltd (formerly Hong Kong Pharma Digital Technology Holdings Ltd.) received a Nasdaq bid-price deficiency notice because its Class A ordinary shares traded below US$1.00 for 30 consecutive business days. The company has 180 calendar days to regain complia", "url": "https://www.theglobeandmail.com/investing/markets/stocks/HKPD-Q/pressreleases/37099649/cellyan-biotechnology-hit-with-nasdaq-bid-price-deficiency-notice-shares-remain-listed/", "source_name": "The Globe and Mail", "published_at": "2026-01-18T12:57:47", "published_display": "18 Jan 2026 12:57", "sentiment": "negative", "sentiment_pct": 20, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cellyan Biotechnology Co., Ltd Receives Nasdaq Notice of Bid Price Deficiency", "summary": "Cellyan Biotechnology Co., Ltd (Nasdaq: HKPD) has received a notice from Nasdaq regarding non-compliance with the minimum bid price requirement. The company's share price was below $1.00 for 30 consecutive business days. Cellyan Biotechnology Co., Ltd has 180 calendar days to reg", "url": "https://www.manilatimes.net/2026/01/17/tmt-newswire/globenewswire/cellyan-biotechnology-co-ltd-receives-nasdaq-notice-of-bid-price-deficiency/2260560", "source_name": "The Manila Times", "published_at": "2026-01-17T21:58:21", "published_display": "17 Jan 2026 21:58", "sentiment": "negative", "sentiment_pct": 29, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cellyan Biotechnology (NASDAQ: HKPD) warned on bid price rule compliance", "summary": "Cellyan Biotechnology (NASDAQ: HKPD) has received a notice from Nasdaq regarding its non-compliance with the minimum bid price requirement. The company's Class A ordinary shares traded below US$1.00 for 30 consecutive business days, triggering the warning. Cellyan Biotechnology h", "url": "https://www.stocktitan.net/sec-filings/HKPD/6-k-cellyan-biotechnology-co-ltd-current-report-foreign-issuer-700aee91ec16.html", "source_name": "Stock Titan", "published_at": "2026-01-16T20:10:12", "published_display": "16 Jan 2026 20:10", "sentiment": "negative", "sentiment_pct": 28, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cellyan Biotechnology (Nasdaq:HKPD) - Stock Analysis", "summary": "This Simply Wall St analysis provides a comprehensive overview of Cellyan Biotechnology (Nasdaq:HKPD), an investment holding company involved in OTC pharmaceutical business in Hong Kong and Mainland China. The report covers its financials, including a market cap of US$7.3m, curre", "url": "https://simplywall.st/stocks/us/transportation/nasdaq-hkpd/cellyan-biotechnology", "source_name": "Simply Wall St", "published_at": "2026-01-03T20:53:11", "published_display": "03 Jan 2026 20:53", "sentiment": "negative", "sentiment_pct": 30, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hong Kong Pharma Digital Technology Announces Board Changes", "summary": "The article \"Hong Kong Pharma Digital Technology Announces Board Changes\" contains no substantive content beyond its title. No further information about the board changes, the company, or relevant dates is provided in the input.", "url": "https://www.msn.com/en-us/money/savingandinvesting/hong-kong-pharma-digital-technology-announces-board-changes/ar-AA1QknFQ?apiversion=v2&domshim=1&noservercache=1&noservertelemetry=1&batchservertelemetry=1&renderwebcomponents=1&wcseo=1", "source_name": "MSN", "published_at": "2025-12-31T00:09:33", "published_display": "31 Dec 2025 00:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hong Kong Pharma Digital Announced Results of 2025 Annual Meeting of Stockholders", "summary": "Hong Kong Pharma Digital Technology Holdings Limited (NASDAQ: HKPD) announced that all proposals presented at its 2025 annual meeting of stockholders on December 12, 2025, were duly passed. Key approvals include the re-election of five directors, ratification of an independent ac", "url": "https://news.futunn.com/en/post/66334011/hong-kong-pharma-digital-announced-results-of-2025-annual-meeting", "source_name": "\u5bcc\u9014\u725b\u725b", "published_at": "2025-12-22T03:22:53", "published_display": "22 Dec 2025 03:22", "sentiment": "positive", "sentiment_pct": 60, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insiders Who Purchased US$6.90m Of Hong Kong Pharma Digital Technology Holdings Stock May Not Have Expected 19% Tumble", "summary": "", "url": "https://news.google.com/rss/articles/CBMi_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?oc=5", "source_name": "simplywall.st", "published_at": "2025-12-03T08:00:00+00:00", "published_display": "03 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hong Kong Pharma Stocks Surge as AIM Vaccine Secures U.S. Clinical Approval for mRNA RSV Vaccine", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1gFBVV95cUxQT3pjVWdQU2FXMm5fRnJXamZSb05xNDdGSXFnazRuWkRyLWMxaTdNaC1ySExJYS1TNHJtTElXWFpfbEh0cjl0dXpLVE5PdjZTY2pQVV9jOEJhcjlmd1J1SVlMbmVpNmNnSlNCZ2p1bWZZTmpnRXRwOVFKTnhtOXlzZ0VJODdlWEdGN3gydFhTX0paOWFNcXBRakR3aVdrajNWM1FLWnZFYzZ2VUpqSXJmaWtSUVBVZjZhSEttUWtDb3Fha1VZTlZfRzJ6TDVqQk5YM2lNaUtR?oc=5", "source_name": "BioPharma APAC", "published_at": "2025-02-27T08:00:00+00:00", "published_display": "27 Feb 2025 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hong Kong Pharma Digital Tech Holdings Ltd Rings the Opening Bell", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxQNlVidlQ1eTRzRUxTQW1lNXVOSXBucnNLVGZSV2xpSWd0LXlhbUtSSFpRT1BMZnloOENfUkphY2UtUzNIMFRlanlKcUhjcDBjTFF1WEpheU51U2JmME9HZ3lfeXJVWmdqMHM5TGtYR0EyWkM5Ynp1VnlxdGx2Ylh2Y3JsYXNZV1JENzZ3QnlPNEVKcHRLZmc?oc=5", "source_name": "Nasdaq", "published_at": "2025-01-23T08:00:00+00:00", "published_display": "23 Jan 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMiX0FVX3lxTE5nVUU1TklYbWRpLWR5SFNwMTFjYjM4S196LWJXd0RVZEd3N3dHeDNDcGRyd3MzVTdIa0dpYTUwbUtvRnlJd3RUejV1ZUxnZXNydVg0NVRxb0hmRFV2bWpV?oc=5", "source_name": "CoinCodex", "published_at": "2025-01-16T08:24:41+00:00", "published_display": "16 Jan 2025 08:24", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HKPD Stock Price and Chart \u2014 NASDAQ:HKPD", "summary": "", "url": "https://news.google.com/rss/articles/CBMiXEFVX3lxTFBEYzl4Y00tT1Vhbk51aExvVll2dXdLT2dpMzR5U01YQk1YX0NGT2NRdkUzem8zOUJNd0VLd3o3WlY0RlhGNlpORUt4dDcteXBNLUR0YkNrMWdUV1Aw?oc=5", "source_name": "TradingView", "published_at": "2025-01-15T18:55:31+00:00", "published_display": "15 Jan 2025 18:55", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 82, "total_relevant": 21, "sentiment_summary": {"positive": 3, "negative": 9, "neutral": 9, "score": 43, "total": 21, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 85, "events": [{"event": "general", "label": "Market update", "weight": 8.25, "count": 15}, {"event": "earnings", "label": "Earnings", "weight": 2.2, "count": 4}, {"event": "macro", "label": "Macro sensitivity", "weight": 0.55, "count": 1}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 0.55, "count": 1}], "positive_events": 3, "negative_events": 9}, "market_context": {"has_market_context": true, "latest_close": 0.45, "latest_week": "2026-07-10", "one_week_move": 2.4, "four_week_move": 8.4, "twelve_week_move": -38.4, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.646838, "market_dynamics_buy_signal": false, "relative_strength": -56.546054, "fair_value_gap": -57.6, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 41.2256, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+2.4% over one week, +8.4% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 68, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "TradingKey", "count": 5}, {"label": "Stock Titan", "count": 4}, {"label": "FinancialContent", "count": 1}, {"label": "Intellectia AI", "count": 1}, {"label": "The Globe and Mail", "count": 1}, {"label": "The Manila Times", "count": 1}, {"label": "Simply Wall St", "count": 1}, {"label": "MSN", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 21}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 15}, {"label": "Earnings", "count": 4}, {"label": "Macro sensitivity", "count": 1}, {"label": "Regulatory and legal", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "43/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "85/100 classification confidence."}, {"label": "Company focus", "value": "21", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+2.4% over one week, +8.4% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Negative", "tone": "negative", "text": "Hong Kong Pharma Digital Technology Holdings Ltd"}], "updated_at": "2026-07-16T10:35:47.257502+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}